Johnson & Johnson
Price data unavailable
Track JNJ in your trading journalAbout Johnson & Johnson
Johnson & Johnson (Nasdaq/NYSE: JNJ) is a Pharmaceuticals company operating within the Health Care sector of the US equity market.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
The company reports trailing twelve-month revenue of $18.47B and net income of $5.24B.
Key metrics include a return on equity of 6.5%, a debt-to-equity ratio of 1.47.
Use FINOTAUR to track JNJ's price action, review fundamentals, and stay current with company news — all in one research dashboard.
Fundamentals
| Revenue (TTM) | $18.47B |
| Net Income (TTM) | $5.24B |
| EPS (TTM) | — |
| P/E Ratio | — |
| Return on Equity | 6.45% |
| Debt-to-Equity | 1.47 |
| Dividend per Share | — |
Recent News
Want real-time analysis on JNJ?
Track it free in your trading journal. Log trades, tag setups, and review your edge.